GMTX

Gemini Therapeutics, Inc.

NASDAQHealthcareBiotechnologyUS

USD1.35

+0.00 (+0.00%)

Company Profile

IPO Date

2020-08-12

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

Market Metrics

Open

$1.36

Prev. Close

$1.35

Day Low

$1.35

Day High

$1.41

52W Low

$1.35

52W High

$24.70

Market Cap

$0.03B

Volume

0.06M

News SentimentBullish

Articles

Avg Positive

31.7%

Avg Negative

1.5%

Avg Neutral

66.8%

News Feed

Gemini Therapeutics Announces Initial Data From Its Ongoing Phase 2a Study of GEM103 in Patients With Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration

Business Wire·6/22/2021·↑ positive

Gemini Therapeutics Reports First Quarter 2021 Financial Results and Provides Business Update

Business Wire·5/13/2021·↑ positive